Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Chiarle

Showing results (111-120 of 156) with videos related to

Pageof 16
Sort By:
Journal of Proteome Research|September 11, 2007
Autoantibody signature in human ductal pancreatic adenocarcinomaBarbara Tomaino, Paola Cappello, Michela Capello, et al.
Genes, Chromosomes & Cancer|August 29, 2025
Comparative DNA Methylation Profiling of Human and Murine ALK-Positive B-Cell NeoplasmsSelina Glaser, Rabea Wagener, Shannon K Harkins, et al.
Cancer Research|September 14, 2014
Modeling lung cancer evolution and preclinical response by orthotopic mouse allograftsChiara Ambrogio, Francisco J Carmona, August Vidal, et al.
Ejhaem|February 10, 2025
Immune Signatures Identify Patient Subsets Deriving Long-Term Benefit From First-Line Rituximab in Follicular LymphomaGinevra Lolli, Alessandro Davini, Valentina Tabanelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2021
IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functionsGianluca Mucciolo, Claudia Curcio, Cecilia Roux, et al.
Blood|October 11, 2008
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCLFrancesco E Boccalatte, Claudia Voena, Chiara Riganti, et al.
Journal of Hematology & Oncology|September 10, 2013
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse modelsMichela Capello, Paola Cappello, Federica Caterina Linty, et al.
Cell Reports|August 1, 2019
CRISPR/Cas9 Screens Reveal Multiple Layers of B cell CD40 RegulationChang Jiang, Stephen J Trudeau, Taek-Chin Cheong, et al.
Nature|May 17, 2023
ERα-associated translocations underlie oncogene amplifications in breast cancerJake June-Koo Lee, Youngsook Lucy Jung, Taek-Chin Cheong, et al.
Oncogene|December 15, 2015
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependencyMonica Ceccon, Maria Elena Boggio Merlo, Luca Mologni, et al.
Pageof 16

Showing results (111-120 of 156) with videos related to

Sort By:
Pageof 16
Journal of Proteome Research|September 11, 2007
Autoantibody signature in human ductal pancreatic adenocarcinomaBarbara Tomaino, Paola Cappello, Michela Capello, et al.
Genes, Chromosomes & Cancer|August 29, 2025
Comparative DNA Methylation Profiling of Human and Murine ALK-Positive B-Cell NeoplasmsSelina Glaser, Rabea Wagener, Shannon K Harkins, et al.
Cancer Research|September 14, 2014
Modeling lung cancer evolution and preclinical response by orthotopic mouse allograftsChiara Ambrogio, Francisco J Carmona, August Vidal, et al.
Ejhaem|February 10, 2025
Immune Signatures Identify Patient Subsets Deriving Long-Term Benefit From First-Line Rituximab in Follicular LymphomaGinevra Lolli, Alessandro Davini, Valentina Tabanelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2021
IL17A critically shapes the transcriptional program of fibroblasts in pancreatic cancer and switches on their protumorigenic functionsGianluca Mucciolo, Claudia Curcio, Cecilia Roux, et al.
Blood|October 11, 2008
The enzymatic activity of 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase is enhanced by NPM-ALK: new insights in ALK-mediated pathogenesis and the treatment of ALCLFrancesco E Boccalatte, Claudia Voena, Chiara Riganti, et al.
Journal of Hematology & Oncology|September 10, 2013
Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse modelsMichela Capello, Paola Cappello, Federica Caterina Linty, et al.
Cell Reports|August 1, 2019
CRISPR/Cas9 Screens Reveal Multiple Layers of B cell CD40 RegulationChang Jiang, Stephen J Trudeau, Taek-Chin Cheong, et al.
Nature|May 17, 2023
ERα-associated translocations underlie oncogene amplifications in breast cancerJake June-Koo Lee, Youngsook Lucy Jung, Taek-Chin Cheong, et al.
Oncogene|December 15, 2015
Excess of NPM-ALK oncogenic signaling promotes cellular apoptosis and drug dependencyMonica Ceccon, Maria Elena Boggio Merlo, Luca Mologni, et al.
Pageof 16